Mesoblast (MESO) Net Margin (2014 - 2023)
Mesoblast (MESO) posted Net Margin of 1181.62% for Q2 2023, down 23.18% sequentially from 959.26% in Q1 2023, and down 22466.0% YoY from N/an in Q2 2022.
Mesoblast (MESO) Net Margin (2014 - 2023) Analysis & Trends
Mesoblast has reported Net Margin for 10 years, with the latest figure at 1181.62% in Q2 2023.
- Quarterly Net Margin fell 22466.0% year-over-year to 1181.62% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 1005.14% (down 11055.0% YoY) and the FY2025 annual result came in at 593.92%, up 89636.0% from the prior year.
- Net Margin retreated to 1181.62% in Q2 2023 per MESO's latest filing, from 959.26% in the prior quarter.
- Over five years, Net Margin peaked at 124.3% in Q2 2020 and troughed at 2396.35% in Q1 2019.
- A 5-year average of 1059.45% and a median of 1056.48% in 2019 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 166291 bps in 2020, down 158782 bps in 2020.
- Over 5 years, Net Margin stood at 1248.55% in 2019, then gained by 8 bps to 1146.45% in 2020, then jumped by 36 bps to 733.74% in 2021, then plunged by 56 bps to 1147.42% in 2022, then declined by 3 bps to 1181.62% in 2023.
- According to Business Quant data, Net Margin over the past three periods registered 1181.62%, 959.26%, and 1147.42% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1,181.62% |
| Mar 31, 2023 | -959.26% |
| Dec 31, 2022 | -1,147.42% |
| Sep 30, 2022 | -760.88% |
| Jun 30, 2022 | -956.96% |
| Mar 31, 2022 | -1,059.27% |
| Dec 31, 2021 | -733.74% |
| Sep 30, 2021 | -934.97% |
| Jun 30, 2021 | -1,105.21% |
| Mar 31, 2021 | -1,354.19% |
| Dec 31, 2020 | -1,146.45% |
| Sep 30, 2020 | -1,880.77% |
| Jun 30, 2020 | -124.30% |
| Mar 31, 2020 | -733.45% |
| Dec 31, 2019 | -1,248.55% |
| Sep 30, 2019 | -292.95% |
| Jun 30, 2019 | -1,053.69% |
| Mar 31, 2019 | -2,396.35% |
| Dec 31, 2018 | -2,021.69% |
| Sep 30, 2018 | -1,780.64% |